Diagnostics™ designs, develops, manufactures, and
markets proprietary noninvasive medical devices that detect
subtle changes in the elasticity of arteries.
It offers CVProfilor DO-2020 and the HD/PulseWave CR-2000
research cardiovascular profiling system.
The company’s products collect 30 seconds of
blood pressure waveform data, perform an analysis of the
digitized blood pressure waveforms, and generate a CVProfile
report that contains information on blood pressure, heart
rate, pulse pressure, body surface area, body mass index,
and both C1-large and C2-small artery elasticity indices.
It sells its products to primary care
physicians, cardiologists, health care professionals, trained medical
personnel, research investigators at academic medical
research centers, government institutes, cardiovascular
specialists, and pharmaceutical firms.
The company markets its products through a
representative organization in the United States.
Hypertension Diagnostics™ was founded in 1988 and is
headquartered in Eagan, Minnesota.